A positive RNS well received by the posters on this board - I am amazed that there has only been one trade this week [5000 shares yesterday morning].
One day, eventually, we will see the true value revealed.
http://pumpedordumped.com/prices/price.php?latest=MAFL
In the RNS dated the 2nd of November they stated:
'Recent hole LS-MS-02 re-assayed and shows meaningful and consistent indium (In) content'
My understanding is that the tests undertaken to measure the zinc, lead copper and tin do not give a reading for indium or selenium, hence the need to re-assay the drill core then. I expect other samples are currently being re-assayed and we will eventually be updated.
'late-breaking podium presentation'26 Jan 2018 09:05
Am I reading too much into the phrase 'late-breaking podium presentation' - to me it reads that the data was so good that:
(a) as already disclosed, they have already received approval for Phase IIb clinical study for a placebo-controlled clinical trial involving 110 patients across 25 clinical trial sites in the US;
(b) the data was deemed worthy enough to qualify as a late-breaking podium presentation.
And, they should still have around �40m in the bank which should keep them funded for another 2 years.